Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by KARASSA, F.B.
Right arrow Articles by MOUTSOPOULOS, H.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KARASSA, F.B.
Right arrow Articles by MOUTSOPOULOS, H.M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2000; 93: 169-174
© 2000 Association of Physicians

Risk factors for central nervous system involvement in systemic lupus erythematosus

F.B. KARASSA, J.P.A. IOANNIDIS1, G. TOULOUMI2, K.A. BOKI and H.M. MOUTSOPOULOS

2 From the Departments of Pathophysiology and Hygiene and Epidemiology, School of Medicine, National University of Athens, Athens, Greece, and 1 Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece, and Department of Medicine, Tufts University School of Medicine, Boston, USA

Received 19 November 1999 We investigated risk factors for central nervous system (CNS) involvement in systemic lupus erythematosus (SLE), in 32 such patients individually matched 1 : 3 to 96 control SLE patients without CNS events. Univariate analysis showed that CNS involvement was significantly associated with the antiphospholipid syndrome (APS) as well as its features: arterial thrombosis, recurrent fetal loss, livedo reticularis and IgG anticardiolipin (aCL) antibodies in high titres. Other potential associations included cutaneous vasculitic lesions, thrombocytopenia, positive ANA, anti-SS-B/La and low serum levels of C3 and C4 complement components, while articular manifestations and discoid rash were significantly less common in patients with neuropsychiatric (NP) disease. In multivariate modeling, CNS involvement was strongly associated with cutaneous vasculitic lesions OR 33, 95% CI 1.5–720) and arterial thromboses (OR 13, 95%CI 0.82–220), and negatively related to the presence of articular manifestations (OR 0.015, 95%CI 0.00–0.17) and discoid rash (OR 0.004, 95%CI 0.00–0.35). Associations with APS-related arterial thromboses and vasculitis point to the importance of arterial vascular pathophysiology in the pathogenesis of NP disease in SLE. Patients with articular manifestations and discoid rash are at very low risk of NP events. Patients with an adverse SLE disease profile may require closer observation and may be the target group for studying pre-emptive interventions.

4 Address correspondence to Professor H.M. Moutsopoulos, Department of Pathophysiology, School of Medicine, National University of Athens, 75 M Asias St, 11527 Athens, Greece. e\|[hyphen]\|mail: hmoutsop{at}dh.uoa.gr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
The Journal of RheumatologyHome page
R. JURENCAK, M. FRITZLER, P. TYRRELL, L. HIRAKI, S. BENSELER, and E. SILVERMAN
Autoantibodies in Pediatric Systemic Lupus Erythematosus: Ethnic Grouping, Cluster Analysis, and Clinical Correlations
J Rheumatol, February 1, 2009; 36(2): 416 - 421.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.